Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: A multicenter study

Giuseppe Di Lorenzo, Alexander Kreuter, Rossella Di Trolio, Attilio Guarini, Carmela Romano, Vincenzo Montesarchio, Norbert H. Brockmeyer, Sabino De Placido, Mark Bower, Bruce J. Dezube

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1578-1580
Number of pages3
JournalJournal of Investigative Dermatology
Issue number6
Publication statusPublished - Jun 2008

ASJC Scopus subject areas

  • Dermatology

Cite this